Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
Bioanalysis|February 4, 2021
The effectiveness of quality control samples in pharmaceutical bioanalysisStephen Keller, Jorge Quiroz, Dave Christopher, et al.
Molecular Systems Biology|July 8, 2011
The auxin signalling network translates dynamic input into robust patterning at the shoot apexTeva Vernoux, Géraldine Brunoud, Etienne Farcot, et al.
Clinical and Translational Science|September 21, 2022
Leveraging patient-centric sampling for clinical drug development and decentralized clinical trials: Promise to realityKatie F Maass, Matthew D Barfield, Mototsugu Ito, et al.
The AAPS Journal|March 12, 2025
Best Practices and Recommendations for Non-Liquid Matrices BioanalysisFaye Vazvaei-Smith, Wenkui Li, Omar S Barnaby, et al.
Molecular & Cellular Proteomics : MCP|April 27, 2023
Meeting Report on the 2nd Chinese American Society for Mass Spectrometry Conference: Advancing Biological and Pharmaceutical Mass SpectrometryYue Chen, Ying Ge, Xianlin Han, et al.
Bioanalysis|November 18, 2015
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 1 - small molecules by LCMS)Jan Welink, Eric Fluhler, Nicola Hughes, et al.
Biomedical Chromatography : BMC|December 10, 2023
Meeting Report on the 3rd Chinese American Society for Mass Spectrometry Conference-Advancing Biological and Pharmaceutical Mass SpectrometryHao Chen, Yunlin Fu, Mei Han, et al.
Bioanalysis|September 28, 2011
2011 White paper on recent issues in bioanalysis and regulatory findings from audits and inspectionsFabio Garofolo, Mario L Rocci, Isabelle Dumont, et al.
Bioanalysis|August 31, 2023
2022 White Paper on Recent Issues in Bioanalysis: ICH M10 BMV Guideline & Global Harmonization; Hybrid Assays; Oligonucleotides & ADC; Non-Liquid & Rare Matrices; Regulatory Inputs (Part 1A - Recommendations on Mass Spectrometry, Chromatography and Sample Preparation, Novel Technologies, Novel Modalities, and Novel Challenges, ICH M10 BMV Guideline & Global Harmonization Part 1B - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine)Matt Szapacs, Wenying Jian, Daniel Spellman, et al.
Bioanalysis|June 24, 2024
2023 White Paper on Recent Issues in Bioanalysis: Deuterated Drugs; LNP; Tumor/FFPE Biopsy; Targeted Proteomics; Small Molecule Covalent Inhibitors; Chiral Bioanalysis; Remote Regulatory Assessments; Sample Reconciliation/Chain of Custody (PART 1A - Recommendations on Mass Spectrometry, Chromatography, Sample Preparation Latest Developments, Challenges, and Solutions and BMV/Regulated Bioanalysis PART 1B - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/IVD/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine)Mike Baratta, Wenying Jian, Shawna Hengel, et al.
Pageof 19